This metabolite has a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 around fifty% of the mother or father drug. Plasma concentrations of this metabolite are roughly 40% of those seen for sildenafil, so which the metabolite accounts for around twenty% of sildenafil's pharmacologic outcomes.Pulmonary arterial hyperten